Business Of Biotech Biopolitics With Allan Shaw
Nov 25, 2024
Allan Shaw, a Renaissance man of biotech, sheds light on the intertwining of politics and the biopharma industry. He discusses the looming impact of U.S. elections on biotech, emphasizing the need for bipartisan support amid eroding public trust in scientific agencies. Shaw delves into the Biosecure Act's potential ramifications and reexamines the future of the Affordable Care Act under new tax policies. The conversation also touches on the relevance of direct-to-consumer pharmaceutical advertising and the imperative for reform in the life sciences sector.
Chapters
Transcript
Episode notes
1 2 3 4 5 6
Intro
00:00 • 4min
Trust Erosion in Science and Health Agencies
04:15 • 29min
Exploring the Future of the Affordable Care Act Amid Tax Cuts
33:12 • 3min
Reevaluating DTC Pharmaceutical Advertising
36:25 • 5min
Future of Life Sciences: Innovation and Reform
41:32 • 6min
Inefficiencies and Innovations in Healthcare and Biotechnology
47:36 • 2min